Exclusive financial advisor to Biocomposites on the sale of the business to TA Associates

About the engagement

KPMG Corporate Finance LLC and KPMG LLP UK (together, “KPMG Corporate Finance”) acted as exclusive financial advisor to Biocomposites (UK) Ltd (“Biocomposites” or “the Company”) on the sale of the business to TA Associates.

Biocomposites is a leading orthobiologics company based in the UK, offering calcium compound devices to regenerate and repair soft bone and tissue. The Company markets Stimulan, a market-leading absorbable calcium sulfate designed to complement a surgeon’s dead space and infection management strategies, and approved for placement directly at the site of infection in bone and soft tissue. Biocomposites has delivered significant growth in the US market, driven primarily by peer-to-peer endorsements of Stimulan among surgeons.

KPMG Corporate Finance was appointed as financial advisor due to its trusted reputation, proven track record in the sector, the firm’s global footprint, and full suite of M&A transaction services. For this transaction, KPMG LLP deployed a fully integrated team, inclusive of Corporate Finance, Debt Advisory, Due Diligence, M&A Tax Advisory, and Private Client Tax Advisory. KPMG LLP ’s comprehensive approach ensured optimal transaction execution and minimal disruption to the Company.

Financial details of this transaction remain confidential.

Global coverage. Industry knowledge. Middle-Market focus.

The global Corporate Finance practices of KPMG International’s network of independent member firms was ranked #1 as the top M&A middle-market adviser globally by Thomson Reuters SDC based on number of completed transactions, and has been named the #1 Global Mid-Market firm and Global Private Equity Mid-Market firm, by Bloomberg M&A Advisory League Tables, for 2016.

KPMG Corporate Finance LLC

KPMG Corporate Finance LLC was recently named Transaction Advisory Firm of the Year by The Global M&A Network, and previously named Investment Bank of the Year by The M&A Advisor. KPMG Corporate Finance LLC provides a broad range of investment banking and advisory services to its domestic and international clients. Our professionals have the experience and depth of knowledge to advise clients on global mergers and acquisitions, sales and divestitures, buyouts, financings, debt restructurings, equity recapitalizations, infrastructure project finance, capital advisory, portfolio solutions, fairness opinions, and other advisory needs.



Jason Moran

Jason Moran

Managing Director, KPMG Corporate Finance LLC

+1 415-963-7353


 
 
Corporate finance services, including Financing, Debt Advisory, and Valuation Services, are not performed by all KPMG member firms and are not offered by member firms in certain jurisdictions due to legal or regulatory constraints. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act upon such information without appropriate professional advice after a thorough examination of the particular situation. 
 
The information contained in this communication may not be representative of the experience of other clients and does not constitute a recommendation, offer, or solicitation to buy, sell or hold any security of any issuer. Past performance does not guarantee future results.
 
© 2019 KPMG Corporate Finance LLC, a Delaware limited liability company. Member FINRA and SIPC. KPMG Corporate  Finance LLC is a subsidiary of KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved.. The KPMG name and logo are registered trademarks or trademarks of KPMG International.